Xcel Hygiene Pharma(India) Private Limited
Founded in 2005 and headquartered in Madhya Pradesh, India.
2005 | Indore, Madhya Pradesh (India) | Active
Xcel Hygiene Pharma(India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2006
- Open Charges ₹ 1.50 M
About Xcel Hygiene Pharma(India)
Xcel Hygiene Pharma(India) Private Limited (XHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2005 and has a history of 19 years and nine months. Its registered office is in Indore, Madhya Pradesh, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2006. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Rajendra Chaudhary and Dilip Kotbagi serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02423MP2005PTC017612
- Company No.
017612
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2005
- Date of AGM
30 Sep 2006
- Date of Balance Sheet
31 Mar 2006
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Who are the key members and board of directors at Xcel Hygiene Pharma(India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Chaudhary  | Director | 18-May-2005 | Current |
| Dilip Kotbagi | Director | 18-May-2005 | Current |
Financial Performance of Xcel Hygiene Pharma(India).
Enhance accessibility to Xcel Hygiene Pharma(India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Xcel Hygiene Pharma(India)?
Unlock access to Xcel Hygiene Pharma(India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹1.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2006 | State Bank Of India | ₹1.50 M | Open |
How Many Employees Work at Xcel Hygiene Pharma(India)?
Unlock and access historical data on people associated with Xcel Hygiene Pharma(India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xcel Hygiene Pharma(India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xcel Hygiene Pharma(India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.